EVIO Inc. Acquires 50% Interest in Keystone Labs Inc.

May 02, 2018

EVIO Inc. (OTCQB:EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, completed its acquisition of a 50% interest in Keystone Labs Inc., for an aggregate purchase price of CDN$2,495,000.

Keystone Labs Inc., located in Edmonton, Alberta, is a privately held Heath Canada accredited testing facility with a GMP establishment license and a Dealer's License under the Narcotic Control Regulations. Keystone offers a full array of analytical and microbiological testing services for pharmaceutical, biotechnology, medical device, nutraceutical, medical cannabis and related industries.

Wildeboer Dellelce LLP acted as counsel to EVIO Inc. in connection with the transaction with a team that included Jeff Hergott, Michael Rennie and Amir Torabi (corporate/mergers & acquisitions) and John Kutkevicius (tax).


Visit website »

Related transactions

No recent transactions.